Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03967938
Title Efficacy of Olaparib in Advanced Cancers Occurring in Patients With Germline Mutations or Somatic Tumor Mutations in Homologous Recombination Genes (1-2018 BSMO)
Acronym 1-2018 BSMO
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AZ-VUB
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL


No variant requirements are available.